Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-02

FDA Approved: FINGOLIMOD — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva's original application for a generic fingolimod product (ANDA 208008). Fingolimod is used to treat relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

ORIG AP for FINGOLIMOD (FINGOLIMOD)